Mark D. Roycik
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protease and Inhibitor Mechanisms 7
- Oncology 6
- Peptidase Inhibition and Analysis 4
- Inflammatory Biomarkers in Disease Prognosis 1
- Co-authors
- Qing‐Xiang Amy Sang (6 shared papers)Jinfeng Zhang (1 shared paper)Paul A. Stewart (1 shared paper)Ghislain Opdenakker (1 shared paper)Howard M. Monroe (1 shared paper)Philippe E. Van den Steen (1 shared paper)Megan E. Muroski (1 shared paper)Xiao Fang (1 shared paper)
- Journals
- PLoS ONE (3 papers)Cell Research (1 paper)Journal of Medicinal Chemistry (1 paper)Current Molecular Medicine (1 paper)Protein Expression and Purification (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Mark D. Roycik
10 papers receiving 360 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 143
- Oncology 116
- Immunology and Allergy 26
- Otorhinolaryngology 12
- Hematology 21
Countries citing papers authored by Mark D. Roycik
This map shows the geographic impact of Mark D. Roycik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Roycik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Roycik more than expected).
Fields of papers citing papers by Mark D. Roycik
This network shows the impact of papers produced by Mark D. Roycik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Roycik. The network helps show where Mark D. Roycik may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Roycik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 110 | |
| 2 | 2013 | 77 | |
| 3 | 2006 | 40 | |
| 4 | 2009 | 40 | |
| 5 | 2013 | 25 | |
| 6 | 2013 | 23 | |
| 7 | 2017 | 16 | |
| 8 | 2013 | 15 | |
| 9 | 2016 | 13 | |
| 10 | 2013 | 9 |
About Mark D. Roycik
Mark D. Roycik is a scholar working on Cancer Research, Oncology, Molecular Biology, Hematology and Genetics, having authored 10 papers that have together received 368 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Signaling Pathways in Disease (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Pulmonary Hypertension Research and Treatments (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Enzyme Production and Characterization (1 paper). The work is most often cited by research in Cancer Research (143 citations), Oncology (116 citations), Immunology and Allergy (26 citations), Otorhinolaryngology (12 citations) and Hematology (21 citations). Mark D. Roycik has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Qing‐Xiang Amy Sang, Jinfeng Zhang, Paul A. Stewart, Ghislain Opdenakker, Howard M. Monroe, Philippe E. Van den Steen, Megan E. Muroski, Xiao Fang, Jeremy S. Myers and Dale B. Bosco. Their work appears in journals such as PLoS ONE, Cell Research, Journal of Medicinal Chemistry, Current Molecular Medicine and Protein Expression and Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.